During the past decade, Instituto Centenario conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Centenario" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Centenario" are "Rheumatoid Arthritis" (3 trials). Many other conditions were trialed in "Instituto Centenario" in a lesser frequency.

Most popular intervention types in "Instituto Centenario" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab 40mg q2w" (1 trials), "Concomitant treatment" (1 trials), "Olokizumab" (1 trials), "Olokizumab 64 mg SC q2w" (1 trials) and "Olokizumab 64 mg SC q4w" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Centenario" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Centenario". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instituto Centenario, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Centenario, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".